Pediatric suspension formulation

The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to admin...

Full description

Saved in:
Bibliographic Details
Main Authors CLANCY, Maurice Joseph Anthony, MCDAID, Dennis Mark, FLYNN, Damien Patrick
Format Patent
LanguageEnglish
Published 07.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to administration. The present disclosure also relates to oral pharmaceutical suspensions comprising water, a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, and one or more buffering agents.
AbstractList The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to administration. The present disclosure also relates to oral pharmaceutical suspensions comprising water, a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, and one or more buffering agents.
Author CLANCY, Maurice Joseph Anthony
FLYNN, Damien Patrick
MCDAID, Dennis Mark
Author_xml – fullname: CLANCY, Maurice Joseph Anthony
– fullname: MCDAID, Dennis Mark
– fullname: FLYNN, Damien Patrick
BookMark eNrjYmDJy89L5WRQCEhNyUwsKcpMViguLS5IzSvOzM9TSMsvyi3NSSwBsnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBkYGxqYWJuZGjoTFxqgAJrihz
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2020358472A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2020358472A13
IEDL.DBID EVB
IngestDate Fri Sep 20 10:13:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2020358472A13
Notes Application Number: AU20200358472
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220407&DB=EPODOC&CC=AU&NR=2020358472A1
ParticipantIDs epo_espacenet_AU2020358472A1
PublicationCentury 2000
PublicationDate 20220407
PublicationDateYYYYMMDD 2022-04-07
PublicationDate_xml – month: 04
  year: 2022
  text: 20220407
  day: 07
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies XEOLAS PHARMACEUTICALS LTD
RelatedCompanies_xml – name: XEOLAS PHARMACEUTICALS LTD
Score 3.3885443
Snippet The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a...
SourceID epo
SourceType Open Access Repository
SubjectTerms BABY COMFORTERS
CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES
DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY
DEVICES FOR RECEIVING SPITTLE
DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Pediatric suspension formulation
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220407&DB=EPODOC&locale=&CC=AU&NR=2020358472A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTIEtgHM0tJ0U9PSUkBXmBnoWiZbpuqmWJgnJaUkmZqnJoIG9H39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQETJPmai5Otq4B_i7-zmrOzsCepJpfEEjOwBg0JWjkCOwrsYIa0qCT9l3DnED7UgqQKxU3QQa2AKB5eSVCDEypecIMnM6wu9eEGTh8oVPeQCY09xWLMCjA79VQKC4tLgAtPc_PUwC1OqF3cIkyKLu5hjh76AKtiof7LN4xFNldxmIMLMA-f6oEg0KycaJJmrlRoiWo15hoAYzuNBOTNMvklBQj0zRgWSnJIIPPJCn80tIMXKCwAi9AMZdhYCkpKk2VBdatJUly4CABAFNEfgs
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTIEtgHM0tJ0U9PSUkBXmBnoWiZbpuqmWJgnJaUkmZqnJoIG9H39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQETJPmai5Otq4B_i7-zmrOzsCepJpfEEjOwBg0JWjkCOwrsZqDzucFNZ7CnED7UgqQKxU3QQa2AKB5eSVCDEypecIMnM6wu9eEGTh8oVPeQCY09xWLMCjA79VQKC4tLgAtPc_PUwC1OqF3cIkyKLu5hjh76AKtiof7LN4xFNldxmIMLMA-f6oEg0KycaJJmrlRoiWo15hoAYzuNBOTNMvklBQj0zRgWSnJIIPPJCn80vIMnB4hvj7xPp5-3tIMXKBwAy9GMZdhYCkpKk2VBdazJUly4OABAGBkgPg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pediatric+suspension+formulation&rft.inventor=CLANCY%2C+Maurice+Joseph+Anthony&rft.inventor=MCDAID%2C+Dennis+Mark&rft.inventor=FLYNN%2C+Damien+Patrick&rft.date=2022-04-07&rft.externalDBID=A1&rft.externalDocID=AU2020358472A1